Cognitive Behavioral Therapy for Insomnia
Trial Summary
What is the purpose of this trial?
Insomnia is a common condition in Veterans, with prevalence rates as high as 53% among treatment-seeking Veterans. Chronic untreated insomnia is associated with increased risk for functional impairment, psychiatric illness, suicidal ideation, unhealthy lifestyles, and decreased quality of life. Cognitive-Behavioral Therapy for Insomnia (CBT-I) is recognized as the first-line treatment for insomnia. Despite its proven efficacy, CBT-I is not always readily provided and/or accessible to Veterans. To address these limitations, behavioral sleep medicine specialists have endeavored to streamline CBT-I through development of time-shortened variations of CBT-I. Although these modifications show promise for advancing care and access, studies comparing brief treatments to standard CBT-I have yet to be performed. This investigation will therefore compare a 4-session brief CBT-I to VA standard 6-session CBT-I to evaluate whether a brief intervention can provide comparable benefits to sleep, functional, and psychiatric outcomes in Veterans with insomnia.
Will I have to stop taking my current medications?
The trial requires that participants have been on a stable medication regimen for at least 4 weeks before joining, so you will not need to stop taking your current medications.
What data supports the effectiveness of the treatment Cognitive Behavioral Therapy for Insomnia?
Research shows that Cognitive Behavioral Therapy for Insomnia (CBT-I) is effective for treating persistent insomnia, even in people with other psychiatric conditions. It is considered the first-choice treatment for both simple insomnia and insomnia that occurs alongside other chronic disorders.12345
Is Cognitive Behavioral Therapy for Insomnia (CBT-I) safe for humans?
How is Cognitive Behavioral Therapy for Insomnia (CBT-I) different from other treatments for insomnia?
Cognitive Behavioral Therapy for Insomnia (CBT-I) is unique because it is a non-drug treatment that focuses on changing sleep habits and misconceptions about sleep, making it the first-line treatment for both simple and complex insomnia cases. Unlike medications, CBT-I can be delivered in various formats, such as brief sessions, online, or even in a single workshop, which helps overcome barriers like cost and access to trained therapists.126910
Research Team
Henry J. Orff, PhD
Principal Investigator
VA San Diego Healthcare System, San Diego, CA
Eligibility Criteria
This trial is for Veterans with insomnia who have an Insomnia Severity Index score over 7, meet the criteria for a mental health disorder, haven't had CBT-I therapy in 2 years, and are on stable meds. It's not for those with certain severe mental illnesses, high suicide risk, other sleep disorders, or recent substance abuse.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline assessment of sleep, functional, and psychiatric outcome measures
Treatment
Randomization and assignment to either 4-session brief CBT-I or 6-session standard CBT-I
Post-treatment Assessment
Assessment of sleep, functional, and psychiatric outcomes after treatment
Follow-up
3-month follow-up assessment to monitor long-term outcomes
Treatment Details
Interventions
- Brief CBT-I (Behavioural Intervention)
- Standard CBT-I (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
Dr. Grant Huang
VA Office of Research and Development
Acting Chief Research and Development Officer
PhD in Medical Psychology and Master of Public Health from the Uniformed Services University of Health Sciences
Dr. Erica M. Scavella
VA Office of Research and Development
Chief Medical Officer since 2022
MD from University of Massachusetts School of Medicine
VA Finger Lakes Healthcare System
Collaborator